Wearables for Chronic Disease Management in Low-Resource African Settings: Promise Meets Practical Limits
A blood pressure cuff and a paper chart have managed hypertension in Nigerian clinics for decades. That basic setup is now being layered with something newer: wristbands, patches, and rings that log heart rate, glucose trends, and activity continuously, without a patient having to remember to write anything down. The question facing African health systems is not whether this technology works, but whether it can survive contact with clinics that sometimes run out of the medicines it is meant to support.
Non-communicable diseases have become one of the defining health burdens on the continent. In Nigeria’s Federal Capital Territory, a study of primary healthcare centres found hypertension affecting an estimated 25 to 40 percent of adults, yet fewer than one in five hypertensive patients were on treatment, and only about 9 percent had their blood pressure under control. The same study found that 59 percent of the facilities surveyed had zero blood pressure medication in stock at the time of assessment. That gap between diagnosis and effective treatment is the backdrop against which every wearable pilot on the continent must be judged.
What Wearables Are Actually Being Tested For
Most of the clinical interest in Africa centres on two conditions: diabetes and hypertension, both of which require frequent, low-cost monitoring rather than occasional hospital tests. A 2025 review in Chronic Diseases and Translational Medicine looked at continuous glucose monitors and fitness trackers across several low- and middle-income countries, including case studies from Ghana and Ethiopia, and found that wearables could meaningfully improve glycaemic control and patient engagement — but that cost, digital illiteracy, and poor integration with existing health records remained persistent obstacles. None of those obstacles are technical in the sense of the device failing to work. They are structural: a glucose sensor that a patient cannot afford to replace, or a dataset that never reaches the doctor who is supposed to act on it, delivers little benefit no matter how accurate its readings are.
A separate strand of research has tested whether consumer-grade wearables — the kind sold in ordinary electronics shops rather than built for clinical trials — can even function reliably outside a hospital setting. A study conducted in rural Burkina Faso and Kenya set out to test the feasibility, acceptability, and accuracy of consumer wearables for generating individual-level health data in low-resource contexts, treating heat stress and cardiovascular strain as an early use case. The underlying logic extends naturally to chronic disease: if a device can withstand dust, heat, and irregular charging access in a Sahelian village, it has cleared a bar that most product testing in wealthier markets never has to meet.
Where Nigeria’s Digital Health Sector Fits In
Nigerian health-tech companies have begun building around this gap rather than waiting for imported devices to be adapted for local conditions. Medlitics, a Lagos-based health technology company, recently launched an AI-powered platform that connects patients, doctors, hospitals, and insurers through a shared system designed to continuously track patient data and flag doctors when intervention may be needed, explicitly targeting the rising cost of treating diabetes and hypertension across African health systems. The platform’s premise reflects a wider recognition in the sector: continuous monitoring only matters if it changes what a clinician does next, and building that link between data and action has been the actual bottleneck, not the sensors themselves.
That thinking also shows up in academic design work closer to the ground. Researchers building a diabetes support tool called Okuma in Port Harcourt interviewed patients and caregivers directly, and the participants raised concerns about data costs, app storage fees, and general discomfort with unfamiliar mobile apps as reasons they might abandon a digital health tool even when they wanted to use it. Nigeria has an estimated 3.6 million people living with type 2 diabetes, and the same research noted a shortage of digital health tools built specifically for that population rather than adapted from products designed elsewhere. Affordability, in other words, is not a side issue to solve after the technology works. In Africa’s low-resource settings, it is part of what “working” has to mean.
The Integration Problem Nobody Has Fully Solved
A broader review of the digital health landscape across sub-Saharan Africa, focused on cardiovascular applications, described a sector where individual tools show promise but rarely connect into a coherent system a clinician can rely on day to day. That pattern recurs across almost every wearable study on the continent: strong pilot results, followed by silence on what happens once the pilot ends and the device has to fit into a clinic’s actual workflow, staffing levels, and electricity supply.
None of this argues against the technology. It argues for treating wearables as one component of a chronic disease system rather than a fix for the system’s weaker parts. A continuous glucose monitor cannot compensate for a pharmacy with no insulin in stock, and a smartwatch flagging an irregular heartbeat is only useful if the flagged patient has somewhere to go. The devices are, by most available evidence, becoming more capable and more affordable each year. Whether African health systems can absorb that capability into clinics still short on medicine, staff, and reliable power is the question that will determine how much difference they actually make.
